172 related articles for article (PubMed ID: 31347948)
1. Intrathecal immunoglobulins and neurofilament light after autologous haematopoietic stem cell transplantation for multiple sclerosis.
Larsson D; Åkerfeldt T; Carlson K; Burman J
Mult Scler; 2020 Oct; 26(11):1351-1359. PubMed ID: 31347948
[TBL] [Abstract][Full Text] [Related]
2. MRI and CSF oligoclonal bands after autologous hematopoietic stem cell transplantation in MS.
Saiz A; Carreras E; Berenguer J; Yagüe J; Martínez C; Marín P; Rovira M; Pujol T; Arbizu T; Graus F
Neurology; 2001 Apr; 56(8):1084-9. PubMed ID: 11320183
[TBL] [Abstract][Full Text] [Related]
3. CSF Free Light Chains as a Marker of Intrathecal Immunoglobulin Synthesis in Multiple Sclerosis: A Blood-CSF Barrier Related Evaluation in a Large Cohort.
Senel M; Mojib-Yezdani F; Braisch U; Bachhuber F; Lewerenz J; Ludolph AC; Otto M; Tumani H
Front Immunol; 2019; 10():641. PubMed ID: 30984199
[No Abstract] [Full Text] [Related]
4. Dynamics of Inflammatory and Neurodegenerative Biomarkers after Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis.
Ruder J; Dinner G; Maceski A; Berenjeno-Correa E; Müller AM; Jelcic I; Kuhle J; Martin R
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142860
[TBL] [Abstract][Full Text] [Related]
5. Oligoclonal restriction of antiviral immunoreaction in oligoclonal band-negative MS patients.
Stich O; Kluge J; Speck J; Rauer S
Acta Neurol Scand; 2015 Jun; 131(6):381-8. PubMed ID: 25402869
[TBL] [Abstract][Full Text] [Related]
6. Biomarkers of demyelination and axonal damage are decreased after autologous hematopoietic stem cell transplantation for multiple sclerosis.
Zjukovskaja C; Larsson A; Cherif H; Kultima K; Burman J
Mult Scler Relat Disord; 2022 Dec; 68():104210. PubMed ID: 36257151
[TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal fluid kappa and lambda free light chains in oligoclonal band-negative patients with suspected multiple sclerosis.
Ferraro D; Trovati A; Bedin R; Natali P; Franciotta D; Santangelo M; Camera V; Vitetta F; Varani M; Trenti T; Gastaldi M; De Biasi S; Nasi M; Pinti M; Meletti S; Sola P
Eur J Neurol; 2020 Mar; 27(3):461-467. PubMed ID: 31710409
[TBL] [Abstract][Full Text] [Related]
8. Investigation of Oligoclonal IgG Bands in Tear Fluid of Multiple Sclerosis Patients.
Hümmert MW; Wurster U; Bönig L; Schwenkenbecher P; Sühs KW; Alvermann S; Gingele S; Skripuletz T; Stangel M
Front Immunol; 2019; 10():1110. PubMed ID: 31164889
[No Abstract] [Full Text] [Related]
9. Baló's concentric sclerosis is immunologically distinct from multiple sclerosis: results from retrospective analysis of almost 150 lumbar punctures.
Jarius S; Würthwein C; Behrens JR; Wanner J; Haas J; Paul F; Wildemann B
J Neuroinflammation; 2018 Jan; 15(1):22. PubMed ID: 29347989
[TBL] [Abstract][Full Text] [Related]
10. Increased intrathecal neurofilament light and immunoglobulin M predict severe disability in relapsing-remitting multiple sclerosis.
Rosenstein I; Rasch S; Axelsson M; Novakova L; Blennow K; Zetterberg H; Lycke J
Front Immunol; 2022; 13():967953. PubMed ID: 36032114
[TBL] [Abstract][Full Text] [Related]
11. Increased cortical lesion load and intrathecal inflammation is associated with oligoclonal bands in multiple sclerosis patients: a combined CSF and MRI study.
Farina G; Magliozzi R; Pitteri M; Reynolds R; Rossi S; Gajofatto A; Benedetti MD; Facchiano F; Monaco S; Calabrese M
J Neuroinflammation; 2017 Feb; 14(1):40. PubMed ID: 28222766
[TBL] [Abstract][Full Text] [Related]
12. Elevated antibody reactivity to measles virus NCORE protein among patients with multiple sclerosis and their healthy siblings with intrathecal oligoclonal immunoglobulin G production.
Persson L; Longhi S; Enarsson J; Andersen O; Haghigi S; Nilsson S; Lagging M; Johansson M; Bergström T
J Clin Virol; 2014 Sep; 61(1):107-12. PubMed ID: 25022622
[TBL] [Abstract][Full Text] [Related]
13. Autologous haematopoietic stem cell transplantation for multiple sclerosis: a position paper and registry outline.
Bayas A; Berthele A; Blank N; Dreger P; Faissner S; Friese MA; Gerdes LA; Grauer OM; Häussler V; Heesen C; Janson D; Korporal-Kuhnke M; Kowarik M; Kröger N; Lünemann JD; Martin R; Meier U; Meuth S; Muraro P; Platten M; Schirmer L; Stürner KH; Stellmann JP; Scheid C; Bergh FT; Warnke C; Wildemann B; Ziemssen T
Ther Adv Neurol Disord; 2023; 16():17562864231180730. PubMed ID: 37780055
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus-specific intrathecal oligoclonal IgG production in relapsing-remitting multiple sclerosis is limited to a subset of patients and is composed of low-affinity antibodies.
Castellazzi M; Contini C; Tamborino C; Fasolo F; Roversi G; Seraceni S; Rizzo R; Baldi E; Tola MR; Bellini T; Granieri E; Fainardi E
J Neuroinflammation; 2014 Nov; 11():188. PubMed ID: 25391491
[TBL] [Abstract][Full Text] [Related]
15. The Immune Signature of CSF in Multiple Sclerosis with and without Oligoclonal Bands: A Machine Learning Approach to Proximity Extension Assay Analysis.
Gaetani L; Bellomo G; Di Sabatino E; Sperandei S; Mancini A; Blennow K; Zetterberg H; Parnetti L; Di Filippo M
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203309
[TBL] [Abstract][Full Text] [Related]
16. [Magnetic resonance findings in the brain of patients with multiple sclerosis without oligoclonal bands in the cerebrospinal fluid].
Mesaroc S; Drulović J; Lević Z; Perić V
Srp Arh Celok Lek; 2003; 131(1-2):31-5. PubMed ID: 14608859
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal fluid abnormalities in a phase III trial of Avonex (IFNbeta-1a) for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group.
Rudick RA; Cookfair DL; Simonian NA; Ransohoff RM; Richert JR; Jacobs LD; Herndon RM; Salazar AM; Fischer JS; Granger CV; Goodkin DE; Simon JH; Bartoszak DM; Bourdette DN; Braiman J; Brownscheidle CM; Coats ME; Cohan SL; Dougherty DS; Kinkel RP; Mass MK; Munchsauer FE; O'Reilly K; Priore RL; Whitham RH
J Neuroimmunol; 1999 Jan; 93(1-2):8-14. PubMed ID: 10378864
[TBL] [Abstract][Full Text] [Related]
18. MRZH reaction increases sensitivity for intrathecal IgG synthesis in IgG Oligoclonal band negative Multiple Sclerosis patients.
Dias-Carneiro RP; von Glehn F; Moraes AS; Boldrini VO; Damasceno A; Andrade MD; Lima AC; Casanova CS; Tilbery CP; Damasceno BP; Santos LM; Brandão CO
J Neuroimmunol; 2016 Nov; 300():30-35. PubMed ID: 27806873
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid cytokines after autologous haematopoietic stem cell transplantation and intrathecal rituximab treatment for multiple sclerosis.
Burman J; Zjukovskaja C; Svenningsson A; Freyhult E; Wiberg A; Kultima K
Brain Commun; 2023; 5(1):fcad011. PubMed ID: 36756308
[TBL] [Abstract][Full Text] [Related]
20. Intermediate-Intensity Autologous Hematopoietic Stem Cell Transplantation Reduces Serum Neurofilament Light Chains and Brain Atrophy in Aggressive Multiple Sclerosis.
Mariottini A; Marchi L; Innocenti C; Di Cristinzi M; Pasca M; Filippini S; Barilaro A; Mechi C; Fani A; Mazzanti B; Biagioli T; Materozzi F; Saccardi R; Massacesi L; Repice AM
Front Neurol; 2022; 13():820256. PubMed ID: 35280289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
